DK1214344T3 - Dipeptidylpeptidaser - Google Patents

Dipeptidylpeptidaser

Info

Publication number
DK1214344T3
DK1214344T3 DK00962085T DK00962085T DK1214344T3 DK 1214344 T3 DK1214344 T3 DK 1214344T3 DK 00962085 T DK00962085 T DK 00962085T DK 00962085 T DK00962085 T DK 00962085T DK 1214344 T3 DK1214344 T3 DK 1214344T3
Authority
DK
Denmark
Prior art keywords
nucleic acids
dipeptidyl peptidase
dipeptidyl
dpp8
dppiv
Prior art date
Application number
DK00962085T
Other languages
Danish (da)
English (en)
Inventor
Catherine Anne Abbott
Mark Douglas Gorell
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ2762A external-priority patent/AUPQ276299A0/en
Priority claimed from AUPQ5709A external-priority patent/AUPQ570900A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Application granted granted Critical
Publication of DK1214344T3 publication Critical patent/DK1214344T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • AIDS & HIV (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00962085T 1999-09-10 2000-09-11 Dipeptidylpeptidaser DK1214344T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ2762A AUPQ276299A0 (en) 1999-09-10 1999-09-10 Peptide and nucleic acid molecule
AUPQ5709A AUPQ570900A0 (en) 2000-02-18 2000-02-18 Peptide and nucleic acid molecule

Publications (1)

Publication Number Publication Date
DK1214344T3 true DK1214344T3 (da) 2006-11-06

Family

ID=25646142

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00962085T DK1214344T3 (da) 1999-09-10 2000-09-11 Dipeptidylpeptidaser

Country Status (9)

Country Link
US (2) US6881564B1 (fr)
EP (1) EP1214344B1 (fr)
JP (1) JP4748908B2 (fr)
AT (1) ATE332366T1 (fr)
CA (1) CA2384135A1 (fr)
DE (1) DE60029230T2 (fr)
DK (1) DK1214344T3 (fr)
ES (1) ES2269178T3 (fr)
WO (1) WO2001019866A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200000815T2 (tr) * 1997-09-29 2000-12-21 Point Therapeutics Inc. In vitro hematopoietik hücrelerin stimulasyonu.
US6979697B1 (en) * 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
JP4748908B2 (ja) * 1999-09-10 2011-08-17 ザ・ユニバーシティ・オブ・シドニー ジペプチジルペプチダーゼ
AU2001257594A1 (en) * 2000-04-18 2001-10-30 Millennium Pharmaceuticals, Inc. 21953, a novel human prolyl oligopeptidase family member and uses thereof
US20040047853A1 (en) * 2000-06-09 2004-03-11 Dahl Soren W Purified proenzyme of dipeptidyl peptidase i (pro-dppi)
AU1313802A (en) 2000-10-12 2002-04-22 Ferring Bv Novel serine protease genes related to dppiv
AUPR107800A0 (en) 2000-10-27 2000-11-23 University Of Sydney, The Peptide and nucleic acid molecule ii
DE10100053A1 (de) * 2001-01-02 2002-08-22 Keyneurotek Ag I G Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
WO2002066627A1 (fr) * 2001-02-16 2002-08-29 Bayer Aktiengesellschaft Regulation de la dipeptidyle peptidase 8 humaine
KR20040015298A (ko) 2001-06-27 2004-02-18 스미스클라인 비참 코포레이션 디펩티딜 펩티다제 억제제로서의 플루오로피롤리딘
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
CA2468192A1 (fr) 2001-11-26 2003-06-05 Trustees Of Tufts College Inhibiteurs peptidomimetiques d'enzymes de clivage post-proline
DE60226517D1 (de) 2002-08-09 2008-06-19 Prosidion Ltd Dipeptidyl peptidase iv inhibitoren zur senkung der chronische gewichtszunahme
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2005106021A1 (fr) * 2004-04-28 2005-11-10 Bayer Healthcare Ag Diagnostics et therapeutique de maladies associees a la dipeptidyle peptidase 8 (dpp8)
WO2005108997A1 (fr) * 2004-05-11 2005-11-17 Bayer Healthcare Ag Diagnostic et therapeutique de maladies associees a la dipeptidyl-peptidase 6 (dpp6)
EP1753730A1 (fr) 2004-06-04 2007-02-21 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidyl peptidase
WO2006019965A2 (fr) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Inhibiteurs de la dipeptidyl peptidase
US20060063719A1 (en) * 2004-09-21 2006-03-23 Point Therapeutics, Inc. Methods for treating diabetes
ZA200802857B (en) 2005-09-14 2009-09-30 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
KR101368988B1 (ko) 2005-09-16 2014-02-28 다케다 야쿠힌 고교 가부시키가이샤 디펩티딜 펩티다제 억제제
WO2007054577A1 (fr) 2005-11-14 2007-05-18 Probiodrug Ag Derives de pyrrolidine a fusion de cyclopropyle, en tant qu'inhibiteurs de dipeptidyle peptidase iv (dp iv)
WO2007112347A1 (fr) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidyl peptidase
WO2007116092A1 (fr) 2006-04-12 2007-10-18 Probiodrug Ag Inhibiteurs d'enzyme
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
BR112017028035A2 (pt) * 2015-06-26 2018-08-28 Dupont Nutrition Biosci Aps aminopeptidases para hidrolisados de proteína
MA47215A (fr) 2017-01-09 2019-11-13 Bioxcel Therapeutics Inc Procédés prédictifs et diagnostiques pour le cancer de la prostate
DE102018107224A1 (de) 2018-02-21 2019-08-22 Immatics Biotechnologies Gmbh Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977085A (en) * 1984-02-29 1990-12-11 The Board Of Regents Of The Univ. Of California Cloning and expression of yeast STE13 and Dpp2 genes encoding dipeptidyl aminopeptidase A and B
US5231126A (en) * 1985-04-01 1993-07-27 Shi Guan Yi Beta-crystalline form of isotactic polypropylene and method for forming the same
CA2277111A1 (fr) * 1997-02-07 1998-08-13 Exxon Chemical Patents, Inc. Compositions elastomeres thermoplastiques obtenues a partir de copolymeres d'olefine ramifies
US20040132158A1 (en) * 1999-01-11 2004-07-08 Incyte Corporation Human peptidases
JP4748908B2 (ja) * 1999-09-10 2011-08-17 ザ・ユニバーシティ・オブ・シドニー ジペプチジルペプチダーゼ
EP2045304B1 (fr) * 1999-12-22 2017-10-11 ExxonMobil Chemical Patents Inc. Compositions adhésives à base de polypropylène
US20030198953A1 (en) * 2000-03-30 2003-10-23 Spytek Kimberly A. Novel proteins and nucleic acids encoding same
AU1313802A (en) * 2000-10-12 2002-04-22 Ferring Bv Novel serine protease genes related to dppiv
US6774069B2 (en) * 2000-12-29 2004-08-10 Kimberly-Clark Worldwide, Inc. Hot-melt adhesive for non-woven elastic composite bonding
US20020123538A1 (en) * 2000-12-29 2002-09-05 Peiguang Zhou Hot-melt adhesive based on blend of amorphous and crystalline polymers for multilayer bonding
US7700707B2 (en) * 2002-10-15 2010-04-20 Exxonmobil Chemical Patents Inc. Polyolefin adhesive compositions and articles made therefrom
US7550528B2 (en) * 2002-10-15 2009-06-23 Exxonmobil Chemical Patents Inc. Functionalized olefin polymers
US7223822B2 (en) * 2002-10-15 2007-05-29 Exxonmobil Chemical Patents Inc. Multiple catalyst and reactor system for olefin polymerization and polymers produced therefrom
CA2499951C (fr) * 2002-10-15 2013-05-28 Peijun Jiang Systeme catalyseur multiple pour la polymerisation d'olefines et polymeres ainsi produits

Also Published As

Publication number Publication date
EP1214344A1 (fr) 2002-06-19
EP1214344B1 (fr) 2006-07-05
JP2003509041A (ja) 2003-03-11
US7148338B2 (en) 2006-12-12
ES2269178T3 (es) 2007-04-01
US20040191826A1 (en) 2004-09-30
WO2001019866A1 (fr) 2001-03-22
US6881564B1 (en) 2005-04-19
JP4748908B2 (ja) 2011-08-17
DE60029230T2 (de) 2007-06-06
CA2384135A1 (fr) 2001-03-22
DE60029230D1 (de) 2006-08-17
ATE332366T1 (de) 2006-07-15
EP1214344A4 (fr) 2004-03-10

Similar Documents

Publication Publication Date Title
DE60029230D1 (de) Dipeptidyl-peptidasen
MXPA02004666A (es) Gelatinas recombinantes.
DK1242452T3 (da) Kimære natriuretiske peptider
EP1553975B8 (fr) Variants fc optimises et methodes destinees a leur generation
AU7381098A (en) Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
MXPA04005266A (es) Inmunocitocinas con selectividad modulada.
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
WO2003011115A3 (fr) Agents de contraste multimères ciblés à base de peptides
EP1381280A4 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
WO2001064834A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
DK1157100T3 (da) Oxaloacetathydrolase-defekte svampeværtsceller
TR199800445A3 (tr) cdc25B geni yükselticisi, hazirlanisi ve kullanimi.
CA95794S (en) Paving stone
WO2001090147A3 (fr) Proteines fluorescentes genetiquement modifiees a grandes longueurs d'onde
NO20003146D0 (no) Ketonperoksyd-derivater, deres fremstilling og anvendelse
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
IT246281Y1 (it) Guarnitura per mobili, in particolare guarnitura di collegamento.
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
DK1196607T3 (da) Antibakterielt chlamysin B-protein, gen kodende derfor samt ekspressionssystem
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
DK0980379T3 (da) Chimære oligonucleotider og deres anvendelse
AU2732101A (en) Identity authentication using transaction history